
    
      OUTLINE:

      Patients undergo F-18 FES PET/CT scan at baseline. Patients also undergo F-18 FES PET/CT and
      FDG PET/CT between 1-12 weeks after starting therapy, and then 1-12 weeks after the second
      FES PET/CT scan. Repeat FDG PET may be omitted in patients on selective estrogen receptor
      degrader.

      After completion of study, patients are followed up for up to 20 years.
    
  